drugset / Trial / NCT00465257

Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar

NCT00465257

Phase 4 Suspended 110 enrolled Karolinska University Hospital
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this study is to assess the efficacy of artesuante + amodiaquine four years after its introduction as first line treatment for uncomplicated childhood malaria in Zanzibar. The hypothesis is that the treatment has a polymerase chain reaction (PCR)adjusted parasitological cure rate of at least 85% 42 days after treatment.

Timeline

Start
2007-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule
Subject amodiaquine Other / unclassified

Indications